Evidence map›Paper›PMID 42150847›Full record

ArticleStatistics in medicine2026

On the Inclusion of Non-Concurrent Controls in Platform Trials With an Interim Analysis.

Pavla Krotka, Martin Posch, Marta Bofill Roig

Abstract read
In one paragraph

Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Pavla KrotkaDepartment of Statistics and Operations Research and Institute for Research and Innovation in Health (IRIS), Universitat Politécnica de Catalunya - BarcelonaTech (UPC), Barcelona, Spain.ORCID https://orcid.org/0000-0001-5727-4270
Martin PoschCenter for Medical Data Science, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0001-8499-8573
Marta Bofill RoigDepartment of Statistics and Operations Research and Institute for Research and Innovation in Health (IRIS), Universitat Politécnica de Catalunya - BarcelonaTech (UPC), Barcelona, Spain.ORCID https://orcid.org/0000-0002-4400-7541

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca 2024 FI-1 00401Departament d'Empresa i Coneixement, Generalitat de Catalunya 2021 SGR 01421Innovative Health Initiative 101165912Ministerio de Ciencia, Innovación y Universidades PID2023-148033OB-C21
6 · The paper itself

Abstract

The analysis of platform trials can be enhanced by utilizing non-concurrent controls. Since including this data might also introduce bias in the treatment effect estimators if time trends are present, methods for incorporating non-concurrent controls adjusting for time have been proposed. However, so far their behavior has not been systematically investigated in platform trials that include interim analyses. To evaluate the impact of an interim analysis in trials utilizing non-concurrent controls, we consider a platform trial featuring two experimental arms and a shared control, with the second experimental arm entering later. We focus on a frequentist regression model that uses non-concurrent controls to estimate the treatment effect of the second arm and adjusts for time using a step function to account for temporal changes. We show that performing an interim analysis in Arm 1 may introduce bias in the point estimation of the effect in Arm 2, if the regression model is used without adjustment, and investigate how the marginal bias and bias conditional on the first arm continuing after the interim depend on different trial design parameters. Moreover, we propose a new estimator of the treatment effect in Arm 2, aiming to eliminate the bias introduced by both the interim analysis in Arm 1 and the time trends, and evaluate its performance in a simulation study. The newly proposed estimator is shown to substantially reduce the bias and type I error rate inflation while leading to power gains compared to an analysis using only concurrent controls.

Indexed as

Clinical Trials as TopicBiasComputer SimulationHumansModels, StatisticalRegression AnalysisResearch Designbias adjustmentinterim analysisnon‐concurrent controlsplatform trialstreatment effect estimation

Identifiers

PMID42150847
PMCPMC13183489

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.